What You Should Know:
– Senseonics Holdings, Inc., a provider of long-term implantable continuous glucose monitoring (CGM) systems, today announced a strategic partnership with Rimidi. Rimidi offers a comprehensive clinical management platform designed to improve…
Continue Reading
In late March, PHTI (Peterson Health Technology Institute) raised the bar for all of us working to digitize healthcare when they issued their first evidence assessment reporting the evaluation of digital diabetes management tools…
Continue Reading
What You Should Know:
– MD Revolution, known for its remote care management solutions, collaborates with Dexcom to integrate cutting-edge continuous glucose monitoring systems into its platform.
– Dexcom, a global leader in real-time continuous glucose monitoring, serves…
Continue Reading
Digital diabetes management tools fail to provide meaningful clinical benefits and increase health spending, a new report from the Peterson Health Technology Institute (PHTI) shows.
This is PHTI’s inaugural report after launching in July as…
What You Should Know:
– Digital diabetes management tools are failing to deliver meaningful health benefits to patients, according to a new evaluation by the Peterson Health Technology Institute (PHTI).
– The report casts doubt on…
Continue Reading
Top News
Digital diabetes management solutions increase healthcare spending without delivering meaningful clinical benefits, according to a review of evidence by the Peterson Health Technology Institute.
The study found that the tools facilitate small, clinically…
What You Should Know: – Know Labs (NYSE American: KNW), a leading innovator in non-invasive medical diagnostic technology, today announced the unveiling of its KnowU™, a wearable, non-invasive continuous glucose monitor (CGM). – With…
Continue Reading
Medicare’s April 2023 decision to increase coverage for continuous glucose monitoring (CGM) was a major development for diabetes management. Now, with over a million new eligible beneficiaries and many more to follow this year,…
Continue Reading
Parkview Health has revolutionized diabetic retinopathy testing, making it more accessible through point-of-care tools. This initiative addresses the challenges of low completion rates due to barriers like time, finances, and transportation. By strategically placing…
Continue Reading
What You Should Know:
– Medicare has significantly expanded access to the Eversense E3 continuous glucose monitoring (CGM) System, a long-lasting and implantable option that offers several advantages over traditional CGMs.
– Medicare has significantly expanded…
Continue Reading
